The DOI matches its Crossref record; 247 of the 247 references it cites were found in a registry or an index.
BCL-2 protein family: attractive targets for cancer therapy
Open accessAbstract
Acquired resistance to cell death is a hallmark of cancer. The BCL-2 protein family members play important roles in controlling apoptotic cell death. Abnormal over-expression of pro-survival BCL-2 family members or abnormal reduction of pro-apoptotic BCL-2 family proteins, both resulting in the inhibition of apoptosis, are frequently detected in diverse malignancies. The critical role of the pro-survival and pro-apoptotic BCL-2 family proteins in the regulation of apoptosis makes them attractive targets for the development of agents for the treatment of cancer. This review describes the roles of the various pro-survival and pro-apoptotic members of the BCL-2 protein family in normal development and organismal function and how defects in the control of apoptosis promote the development and therapy resistance of cancer. Finally, we discuss the development of inhibitors of pro-survival BCL-2 proteins, termed BH3-mimetic drugs, as novel agents for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–247 of 247
Role of bax Mutations in Apoptosis in Colorectal Cancers With Microsatellite Instability
Miquel, C., Borrini, F., Grandjouan, S., Auperin, A., Viguier, J., Velasco, V., Duvillard, P., Praz, F., & Sabourin, J. (2005) · American Journal of Clinical Pathology · doi:10.1309/jq2x-3rv3-l8f9-tgyw · Cited by 80
Phosphorylation of Puma modulates its apoptotic function by regulating protein stability
Fricker, M., O’Prey, J., Tolkovsky, A. M., & Ryan, K. M. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.38 · Cited by 79
Bax, Bcl-2, and p53 Expression in Endometrial Cancer
Sakuragi, N., Salah-Eldin, A.-E., Watari, H., Itoh, T., Inoue, S., Moriuchi, T., & Fujimoto, S. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6742 · Cited by 78
IL‐15 regulates Bcl‐2 family members Bim and Mcl‐1 through JAK/STAT and PI3K/AKT pathways in T cells
Shenoy, A. R., Kirschnek, S., & Häcker, G. A. (2014) · European Journal of Immunology · doi:10.1002/eji.201344238 · Cited by 74
MCL-1 dependency of cisplatin-resistant cancer cells
Michels, J., Obrist, F., Vitale, I., Lissa, D., Garcia, P., Behnam‐Motlagh, P., Kohno, K., Wu, G. S., Brenner, C., Castedo, M., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.029 · Cited by 74
Schenk, R. L., Tuzlak, S., Carrington, E. M., Zhan, Y., Heinzel, S., Teh, C. E., Gray, D. H. D., Tai, L., Lew, A. M., Villunger, A., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2016.156 · Cited by 74
Self-citationMCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically
Munkhbaatar, E., Dietzen, M., Agrawal, D., Anton, M., Jesinghaus, M., Boxberg, M., Pfarr, N., Bidola, P., Uhrig, S., Höckendorf, U., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18372-1 · Cited by 70
Self-citationThe Stability and Anti-apoptotic Function of A1 Are Controlled by Its C Terminus
Herold, M. J., Zeitz, J., Pelzer, C., Kraus, C., Peters, A., Wohlleben, G., & Berberich, I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600266200 · Cited by 69
Craxton, A., Butterworth, M., Harper, N. W., Fairall, L., Schwabe, J. W. R., Ciechanover, A. J., & Cohen, G. M. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.16 · Cited by 68
Bcl-w expression in colorectal adenocarcinoma
Wilson, J. W., Nostro, M. C., Balzi, M., Faraoni, P., Cianchi, F., Becciolini, A., & Potten, C. S. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0897 · Cited by 67
Martin, A. P., Miller, A. V., Emad, L., Rahmani, M., Walker, T. D., Mitchell, C., Hagan, M. P., Park, M. A., Yacoub, A., Fisher, P. B., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.047365 · Cited by 67
Ottina, E., Grespi, F., Tischner, D., Soratroi, C., Geley, S., Ploner, A., Reichardt, H. M., Villunger, A., & Herold, M. J. (2012) · Blood · doi:10.1182/blood-2011-12-399089 · Cited by 61
Lallemand, C., Blanchard, B., Palmieri, M., Lebon, P., May, E., & Tovey, M. G. (2006) · Oncogene · doi:10.1038/sj.onc.1209795 · Cited by 58
Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells
Loar, P., Wahl, H. N., Kshirsagar, M. P., Gossner, G., Griffith, K. A., & Liu, J. R. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.10.883 · Cited by 56
Weiler, M., Bähr, O., Hohlweg, U., Naumann, U., Rieger, J., Huang, H., Tabatabai, G., Krell, H. W., Ohgaki, H., Weller, M., et al. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401786 · Cited by 56
Osaki, S., Tazawa, H., Hasei, J., Yamakawa, Y., Omori, T., Sugiu, K., Komatsubara, T., Fujiwara, T., Sasaki, T., Kunisada, T., et al. (2016) · Scientific Reports · doi:10.1038/srep28953 · Cited by 54
BCL-W has a fundamental role in B cell survival and lymphomagenesis
Adams, C. M., Kim, A. S., Mitra, R., Choi, J. K., Gong, J. Z., & Eischen, C. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89486 · Cited by 54
Yasuda, Y., Ozasa, H., Kim, Y. H., Yamazoe, M., Ajimizu, H., Funazo, T. Y., Nomizo, T., Tsuji, T., Yoshida, H., Sakamori, Y., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2379-2 · Cited by 54
BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer
Ramesh, P., Lannagan, T. R. M., Jackstadt, R., Atencia Taboada, L., Lansu, N., Wirapati, P., van Hooff, S. R., Dekker, D., Pritchard, J., Kirov, A. B., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00816-w · Cited by 52
Zhao, Y., Zhang, C.-L., Zeng, B.-F., Wu, X.-S., Gao, T.-T., & Oda, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.020 · Cited by 50
Toward Targeting Antiapoptotic MCL-1 for Cancer Therapy
Kelly, G. L., & Strasser, A. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033510 · Cited by 50
Self-citationSurvival control of malignant lymphocytes by anti-apoptotic MCL-1
Fernández‐Marrero, Y., Spinner, S., Kaufmann, T., & Jost, P. J. (2016) · Leukemia · doi:10.1038/leu.2016.213 · Cited by 46
Ma, S., Seymour, J. F., Brander, D. M., Kipps, T. J., Choi, M. Y., Anderson, M. A., Humphrey, K., Masud, A. A., Pesko, J. C., Nandam, R., et al. (2021) · Blood · doi:10.1182/blood.2020009578 · Cited by 46
Grabow, S., Delbridge, A. R. D., Valente, L. J., & Strasser, A. (2014) · Blood · doi:10.1182/blood-2014-09-601567 · Cited by 45
Self-citationPan, B., Wang, D., Li, L., Shang, L., Xia, F., Zhang, F., Zhang, Y., Gale, R. P., Xu, M., Li, Z., et al. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.06.002 · Cited by 45
Roles and Regulation of BCL-xL in Hematological Malignancies
Morales-Martínez, M., & Vega, M. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042193 · Cited by 44
Hernández-Luna, M. A., Rocha‐Zavaleta, L., Vega, M. I., & Huerta‐Yépez, S. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.733874 · Cited by 41
Subtle Changes in the Levels of BCL-2 Proteins Cause Severe Craniofacial Abnormalities
Grabow, S., Kueh, A. J., Ke, F., Vanyai, H. K., Sheikh, B. N., Dengler, M. A., Chiang, W., Eccles, S., Smyth, I., Jones, L. K., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.048 · Cited by 41
Self-citationCherla, R. P., Zhang, Y., Ledbetter, L., & Zhang, G. (2018) · Infection and Immunity · doi:10.1128/iai.00504-17 · Cited by 37
NF-Y is essential for expression of the proapoptotic bim gene in sympathetic neurons
Hughes, R., Kristiansen, M., Lassot, I., Desagher, S., Mantovani, R., & Ham, J. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.166 · Cited by 36
The BCL-2 pro-survival protein A1 is dispensable for T cell homeostasis on viral infection
Tuzlak, S., Schenk, R. L., Vasanthakumar, A., Preston, S., Haschka, M. D., Zotos, D., Kallies, A., Strasser, A., Villunger, A., & Herold, M. J. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2016.155 · Cited by 36
Self-citationNguyen, H. V., Vandenberg, C. J., Ng, A. P., Robati, M., Anstee, N. S., Rimes, J. S., Hawkins, E. D., & Cory, S. (2020) · Blood · doi:10.1182/blood.2019003014 · Cited by 34
MCL1 Is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice
Healy, M. E., Boege, Y., Hodder, M. C., Böhm, F., Malehmir, M., Scherr, A., Jetzer, J., Chan, L. K., Parrotta, R., Jacobs, K., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.017 · Cited by 33
Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival
Sochalska, M., Ottina, E., Tuzlak, S., Herzog, S., Herold, M. J., & Villunger, A. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.130 · Cited by 32
The Bcl-w promoter is activated by β-catenin/TCF4 in human colorectal carcinoma cells
Lapham, A. S., Adams, J. E., Paterson, A. R., Lee, M., Brimmell, M., & Packham, G. (2008) · Gene · doi:10.1016/j.gene.2008.12.002 · Cited by 30
Choi, B., Chun, E., Kim, S. Y., Kim, M.-Y., Lee, K.-Y., & Kim, S. J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.030 · Cited by 29
Herold, M. J., Rohrbeck, L., Lang, M. J., Grumont, R. J., Gerondakis, S., Tai, L., Bouillet, P., Kaufmann, T., & Strasser, A. (2013) · EMBO Reports · doi:10.1038/embor.2013.152 · Cited by 28
Self-citationOlie, R. A., & Zangemeister‐Wittke, U. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0181 · Cited by 27
Brinkmann, K., Ng, A. P., de Graaf, C. A., & Strasser, A. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00987-0 · Cited by 26
Self-citationRequirement for antiapoptotic MCL-1 during early erythropoiesis
Turnis, M. E., Kaminska, E. K., Smith, K. H., Kartchner, B. J., Vogel, P., Laxton, J. D., Ashmun, R. A., Ney, P. A., & Opferman, J. T. (2021) · Blood · doi:10.1182/blood.2020006916 · Cited by 25
Knockdown of the Antiapoptotic Bcl-2 Family Member A1/Bfl-1 Protects Mice from Anaphylaxis
Ottina, E., Lyberg, K., Sochalska, M., Villunger, A., & Nilsson, G. P. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400637 · Cited by 22
Véronèse, L., Tournilhac, O., Verrelle, P., Davi, F., Dighiero, G., Chautard, E., Veyrat‐Masson, R., Kwiatkowski, F., Goumy, C., Gouas, L., et al. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.05.003 · Cited by 21
Diepstraten, S. T., Chang, C. W. T., Tai, L., Gong, J., Lan, P., Dowell, A. C., Taylor, G. S., Strasser, A., & Kelly, G. L. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000541 · Cited by 20
Self-citationSejic, N., George, L. C., Tierney, R. J., Chang, C. W. T., Kondrashova, O., MacKinnon, R. N., Lan, P., Bell, A. I., Lessène, G., Long, H. M., et al. (2020) · PubMed · doi:10.1182/bloodadvances.2020002446 · Cited by 20
Self-citationContext-specific regulation of cell survival by a miRNA-controlled BIM rheostatPreprint
Labi, V., Peng, S., Klironomos, F., Munschauer, M., Kastelić, N., Chakraborty, T., Schoeler, K., Derudder, E., Martella, M., Mastrobuoni, G., et al. (2019) · Genes & Development · doi:10.1101/gad.330134.119 · Cited by 17
Bcl-xl Expression in Multiple Myeloma
Peeters, S. D. P. W. M., Hovenga, S., Rosati, S., & Vellenga, E. (2005) · Medical Oncology · doi:10.1385/mo:22:2:183 · Cited by 11
BCL‐XL exerts a protective role against anemia caused by radiation‐induced kidney damage
Brinkmann, K., Waring, P., Glaser, S. P., Wimmer, V. C., Cottle, D. L., Tham, M. S., Nhu, D., Whitehead, L. W., Delbridge, A. R. D., Lessène, G., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020105561 · Cited by 10
Self-citation
Cited by
Targeted protein degradation: advances in drug discovery and clinical practice
Zhong, G., Chang, X., Xie, W., & Zhou, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02004-x · Cited by 326
Shao, M., Zhang, X., Sun, J., Dong, H., Han, X., Yang, Q., Chen, R., Shen, L., Xu, L., Wang, L., et al. (2025) · Exploration · doi:10.1002/exp.70000 · Cited by 26
Metadata
- Authors
- Kaloni, D., Diepstraten, S. T., Strasser, A., & Kelly, G. L.
- Venue
- Apoptosis
- Published
- 2022-11-07
- Volume
- 28
- Issue
- 1-2
- Pages
- 20-38
- ISSN
- 1360-8185 (ISSN-L)
- 1573-675X
- OpenAlex
- W4308365352
- Cited by
- 500
- References
- 247
- FWCI
- 27.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.